Association  ||| S:0 E:12 ||| NNP
between  ||| S:12 E:20 ||| IN
Periodontitis  ||| S:20 E:34 ||| NNP
and  ||| S:34 E:38 ||| CC
mortality  ||| S:38 E:48 ||| NN
in  ||| S:48 E:51 ||| IN
stages  ||| S:51 E:58 ||| NNS
3-5  ||| S:58 E:62 ||| NNP
Chronic  ||| S:62 E:70 ||| NNP
Kidney  ||| S:70 E:77 ||| NNP
Disease ||| S:77 E:84 ||| NNP
:  ||| S:84 E:86 ||| :
NHANES  ||| S:86 E:93 ||| NNP
III  ||| S:93 E:97 ||| NNP
and  ||| S:97 E:101 ||| CC
linked  ||| S:101 E:108 ||| VBN
mortality  ||| S:108 E:118 ||| NN
study  ||| S:118 E:124 ||| NN
Periodontitis  ||| S:124 E:138 ||| NNP
may  ||| S:138 E:142 ||| MD
add  ||| S:142 E:146 ||| VB
to  ||| S:146 E:149 ||| TO
the  ||| S:149 E:153 ||| DT
systemic  ||| S:153 E:162 ||| JJ
inflammatory  ||| S:162 E:175 ||| JJ
burden  ||| S:175 E:182 ||| NN
in  ||| S:182 E:185 ||| IN
individuals  ||| S:185 E:197 ||| NNS
with  ||| S:197 E:202 ||| IN
chronic  ||| S:202 E:210 ||| JJ
kidney  ||| S:210 E:217 ||| NN
disease  ||| S:217 E:225 ||| NN
( ||| S:225 E:226 ||| -LRB-
CKD ||| S:226 E:229 ||| NNP
) ||| S:229 E:230 ||| -RRB-
,  ||| S:230 E:232 ||| ,
thereby  ||| S:232 E:240 ||| RB
contributing  ||| S:240 E:253 ||| VBG
to  ||| S:253 E:256 ||| TO
an  ||| S:256 E:259 ||| DT
increased  ||| S:259 E:269 ||| JJ
morality  ||| S:269 E:278 ||| NN
rate ||| S:278 E:282 ||| NN
.  ||| S:282 E:284 ||| .
This  ||| S:284 E:289 ||| DT
study  ||| S:289 E:295 ||| NN
aimed  ||| S:295 E:301 ||| VBN
to  ||| S:301 E:304 ||| TO
determine  ||| S:304 E:314 ||| VB
the  ||| S:314 E:318 ||| DT
association  ||| S:318 E:330 ||| NN
between  ||| S:330 E:338 ||| IN
periodontitis  ||| S:338 E:352 ||| NN
and  ||| S:352 E:356 ||| CC
mortality  ||| S:356 E:366 ||| NN
rate  ||| S:366 E:371 ||| NN
( ||| S:371 E:372 ||| -LRB-
all-cause  ||| S:372 E:382 ||| NNP
and  ||| S:382 E:386 ||| CC
cardiovascular  ||| S:386 E:401 ||| JJ
disease-  ||| S:401 E:410 ||| JJ
related ||| S:410 E:417 ||| JJ
)  ||| S:417 E:419 ||| -RRB-
in  ||| S:419 E:422 ||| IN
individuals  ||| S:422 E:434 ||| NNS
with  ||| S:434 E:439 ||| IN
stage  ||| S:439 E:445 ||| NN
3-5  ||| S:445 E:449 ||| NNP
CKD ||| S:449 E:452 ||| NNP
,  ||| S:452 E:454 ||| ,
hitherto  ||| S:454 E:463 ||| VBD
referred  ||| S:463 E:472 ||| VBN
to  ||| S:472 E:475 ||| TO
as  ||| S:475 E:478 ||| IN
CKD ||| S:478 E:481 ||| NNP
.  ||| S:481 E:483 ||| .
Survival  ||| S:483 E:492 ||| NN
analysis  ||| S:492 E:501 ||| NN
was  ||| S:501 E:505 ||| VBD
carried  ||| S:505 E:513 ||| VBN
out  ||| S:513 E:517 ||| RP
using  ||| S:517 E:523 ||| VBG
the  ||| S:523 E:527 ||| DT
Third  ||| S:527 E:533 ||| NNP
National  ||| S:533 E:542 ||| NNP
Health  ||| S:542 E:549 ||| NNP
and  ||| S:549 E:553 ||| CC
Nutrition  ||| S:553 E:563 ||| NNP
Examination  ||| S:563 E:575 ||| NNP
Survey  ||| S:575 E:582 ||| NNP
( ||| S:582 E:583 ||| -LRB-
NHANES  ||| S:583 E:590 ||| NNP
III ||| S:590 E:593 ||| NNP
)  ||| S:593 E:595 ||| -RRB-
and  ||| S:595 E:599 ||| CC
linked  ||| S:599 E:606 ||| VBN
mortality  ||| S:606 E:616 ||| NN
data ||| S:616 E:620 ||| NNS
.  ||| S:620 E:622 ||| .
Cox  ||| S:622 E:626 ||| NNP
proportional  ||| S:626 E:639 ||| VBD
hazards  ||| S:639 E:647 ||| JJ
regression  ||| S:647 E:658 ||| NN
was  ||| S:658 E:662 ||| VBD
employed  ||| S:662 E:671 ||| VBN
to  ||| S:671 E:674 ||| TO
assess  ||| S:674 E:681 ||| VB
the  ||| S:681 E:685 ||| DT
association  ||| S:685 E:697 ||| NN
between  ||| S:697 E:705 ||| IN
periodontitis  ||| S:705 E:719 ||| NN
and  ||| S:719 E:723 ||| CC
mortality ||| S:723 E:732 ||| NN
,  ||| S:732 E:734 ||| ,
in  ||| S:734 E:737 ||| IN
individuals  ||| S:737 E:749 ||| NNS
with  ||| S:749 E:754 ||| IN
CKD ||| S:754 E:757 ||| NNP
.  ||| S:757 E:759 ||| .
This  ||| S:759 E:764 ||| DT
association  ||| S:764 E:776 ||| NN
was  ||| S:776 E:780 ||| VBD
compared  ||| S:780 E:789 ||| VBN
with  ||| S:789 E:794 ||| IN
the  ||| S:794 E:798 ||| DT
association  ||| S:798 E:810 ||| NN
between  ||| S:810 E:818 ||| IN
mortality  ||| S:818 E:828 ||| NN
and  ||| S:828 E:832 ||| CC
traditional  ||| S:832 E:844 ||| JJ
risk  ||| S:844 E:849 ||| NN
factors  ||| S:849 E:857 ||| NNS
in  ||| S:857 E:860 ||| IN
CKD  ||| S:860 E:864 ||| NNP
mortality  ||| S:864 E:874 ||| NN
( ||| S:874 E:875 ||| -LRB-
diabetes ||| S:875 E:883 ||| NN
,  ||| S:883 E:885 ||| ,
hypertension  ||| S:885 E:898 ||| NN
and  ||| S:898 E:902 ||| CC
smoking ||| S:902 E:909 ||| NN
) ||| S:909 E:910 ||| -RRB-
.  ||| S:910 E:912 ||| .
Of  ||| S:912 E:915 ||| IN
the  ||| S:915 E:919 ||| DT
13,784  ||| S:919 E:926 ||| CD
participants  ||| S:926 E:939 ||| NNS
eligible  ||| S:939 E:948 ||| JJ
for  ||| S:948 E:952 ||| IN
analysis  ||| S:952 E:961 ||| NN
in  ||| S:961 E:964 ||| IN
NHANES  ||| S:964 E:971 ||| NNP
III ||| S:971 E:974 ||| NNP
,  ||| S:974 E:976 ||| ,
861  ||| S:976 E:980 ||| CD
( ||| S:980 E:981 ||| -LRB-
6 ||| S:981 E:982 ||| CD
% ||| S:982 E:983 ||| NN
)  ||| S:983 E:985 ||| -RRB-
had  ||| S:985 E:989 ||| VBD
CKD ||| S:989 E:992 ||| NNP
.  ||| S:992 E:994 ||| .
The  ||| S:994 E:998 ||| DT
median  ||| S:998 E:1005 ||| JJ
follow-up  ||| S:1005 E:1015 ||| NN
for  ||| S:1015 E:1019 ||| IN
this  ||| S:1019 E:1024 ||| DT
cohort  ||| S:1024 E:1031 ||| NN
was  ||| S:1031 E:1035 ||| VBD
14.3  ||| S:1035 E:1040 ||| CD
years ||| S:1040 E:1045 ||| NNS
.  ||| S:1045 E:1047 ||| .
Adjusting  ||| S:1047 E:1057 ||| VBG
for  ||| S:1057 E:1061 ||| IN
confounders ||| S:1061 E:1072 ||| NN
,  ||| S:1072 E:1074 ||| ,
the  ||| S:1074 E:1078 ||| DT
10  ||| S:1078 E:1081 ||| CD
year  ||| S:1081 E:1086 ||| NN
all-cause  ||| S:1086 E:1096 ||| JJ
mortality  ||| S:1096 E:1106 ||| NN
rate  ||| S:1106 E:1111 ||| NN
for  ||| S:1111 E:1115 ||| IN
individuals  ||| S:1115 E:1127 ||| NNS
with  ||| S:1127 E:1132 ||| IN
CKD  ||| S:1132 E:1136 ||| NNP
increased  ||| S:1136 E:1146 ||| VBD
from  ||| S:1146 E:1151 ||| IN
32 ||| S:1151 E:1153 ||| CD
% ||| S:1153 E:1154 ||| NN
( ||| S:1154 E:1155 ||| -LRB-
95 ||| S:1155 E:1157 ||| CD
% ||| S:1157 E:1158 ||| NN
CI ||| S:1158 E:1160 ||| NNP
: ||| S:1160 E:1161 ||| :
29-35 ||| S:1161 E:1166 ||| CD
% ||| S:1166 E:1167 ||| NN
)  ||| S:1167 E:1169 ||| -RRB-
to  ||| S:1169 E:1172 ||| TO
41 ||| S:1172 E:1174 ||| CD
% ||| S:1174 E:1175 ||| NN
( ||| S:1175 E:1176 ||| -LRB-
36-47 ||| S:1176 E:1181 ||| NNP
% ||| S:1181 E:1182 ||| NN
)  ||| S:1182 E:1184 ||| -RRB-
with  ||| S:1184 E:1189 ||| IN
the  ||| S:1189 E:1193 ||| DT
addition  ||| S:1193 E:1202 ||| NN
of  ||| S:1202 E:1205 ||| IN
periodontitis ||| S:1205 E:1218 ||| NN
.  ||| S:1218 E:1220 ||| .
For  ||| S:1220 E:1224 ||| IN
diabetes ||| S:1224 E:1232 ||| NN
,  ||| S:1232 E:1234 ||| ,
the  ||| S:1234 E:1238 ||| DT
10  ||| S:1238 E:1241 ||| CD
year  ||| S:1241 E:1246 ||| NN
all-cause  ||| S:1246 E:1256 ||| JJ
mortality  ||| S:1256 E:1266 ||| NN
rate  ||| S:1266 E:1271 ||| NN
increased  ||| S:1271 E:1281 ||| VBD
to  ||| S:1281 E:1284 ||| TO
43 ||| S:1284 E:1286 ||| CD
% ||| S:1286 E:1287 ||| NN
( ||| S:1287 E:1288 ||| -LRB-
38-49 ||| S:1288 E:1293 ||| NNP
% ||| S:1293 E:1294 ||| NN
) ||| S:1294 E:1295 ||| -RRB-
.  ||| S:1295 E:1297 ||| .
There  ||| S:1297 E:1303 ||| EX
is  ||| S:1303 E:1306 ||| VBZ
a  ||| S:1306 E:1308 ||| DT
strong ||| S:1308 E:1314 ||| JJ
,  ||| S:1314 E:1316 ||| ,
association  ||| S:1316 E:1328 ||| NN
between  ||| S:1328 E:1336 ||| IN
periodontitis  ||| S:1336 E:1350 ||| NN
and  ||| S:1350 E:1354 ||| CC
increased  ||| S:1354 E:1364 ||| JJ
mortality  ||| S:1364 E:1374 ||| NN
in  ||| S:1374 E:1377 ||| IN
individuals  ||| S:1377 E:1389 ||| NNS
with  ||| S:1389 E:1394 ||| IN
CKD ||| S:1394 E:1397 ||| NNP
.  ||| S:1397 E:1399 ||| .
Sources  ||| S:1399 E:1407 ||| NNS
of  ||| S:1407 E:1410 ||| IN
chronic  ||| S:1410 E:1418 ||| JJ
systemic  ||| S:1418 E:1427 ||| JJ
inflammation  ||| S:1427 E:1440 ||| NNS
( ||| S:1440 E:1441 ||| -LRB-
including  ||| S:1441 E:1451 ||| VBG
periodontitis ||| S:1451 E:1464 ||| NN
)  ||| S:1464 E:1466 ||| -RRB-
may  ||| S:1466 E:1470 ||| MD
be  ||| S:1470 E:1473 ||| VB
important  ||| S:1473 E:1483 ||| JJ
contributors  ||| S:1483 E:1496 ||| NNS
to  ||| S:1496 E:1499 ||| TO
mortality  ||| S:1499 E:1509 ||| NN
in  ||| S:1509 E:1512 ||| IN
patients  ||| S:1512 E:1521 ||| NNS
with  ||| S:1521 E:1526 ||| IN
CKD ||| S:1526 E:1529 ||| NNP
.  ||| S:1529 E:1531 ||| .
This  ||| S:1531 E:1536 ||| DT
article  ||| S:1536 E:1544 ||| NN
is  ||| S:1544 E:1547 ||| VBZ
protected  ||| S:1547 E:1557 ||| VBN
by  ||| S:1557 E:1560 ||| IN
copyright ||| S:1560 E:1569 ||| NN
.  ||| S:1569 E:1571 ||| .
All  ||| S:1571 E:1575 ||| DT
rights  ||| S:1575 E:1582 ||| NNS
reserved ||| S:1582 E:1590 ||| VBN
.  ||| S:1590 E:1592 ||| .
